Tardiveau C, et al. and the RICO study group (2022) A 9-mRNA signature measured from whole blood by a prototype PCR panel predicts 28-day mortality upon admission of critically ill COVID-19 patients. Front. Immunol. 13:1022750. doi: https://t.co/0eDIu51cwz
RT @FrontImmunol: New Research: A 9-mRNA signature measured from whole blood by a prototype PCR panel predicts 28-day mortality upon admiss…
New Research: A 9-mRNA signature measured from whole blood by a prototype PCR panel predicts 28-day mortality upon admission of critically ill COVID-19 patients: Immune responses affiliated with COVID-19 severity have been characterized and… https://t.co/c